Applying multiple interventions in chronic kidney disease

被引:18
作者
Barrett, BJ
机构
[1] Mem Univ Newfoundland, Dept Med, Div Nephrol, St John, NF, Canada
[2] Mem Univ Newfoundland, Dept Med, Clin Epidemiol Unit, St John, NF, Canada
关键词
D O I
10.1046/j.1525-139X.2003.16032.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The medical, social, and financial burdens posed by end-stage renal disease (ESRD) are many and growing rapidly. People generally reach ESRD as a result of chronic progressive kidney disease. Advancing kidney disease is associated with several treatable complications, which if poorly managed reduce the length and quality of life. In addition, there are strong links between chronic kidney disease (CKD) and cardiovascular disease (CVD). Many people with less advanced CKD will die or suffer complications of CVD before reaching ESRD. Efficacious interventions, such as lowering blood pressure and treating dyslipidemia, can substantially reduce the progression of both kidney and cardiovascular disease. Careful management of these complex and interrelated diseases and risk factors requires detailed longitudinal and focused care which does not seem to be optimally delivered by health service practitioners organized in traditional ways. A disease management approach offers promise in this setting, but requires further study of clinical and economic impact.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 163 条
[1]  
*AM NURS ASS, 1993, EX SUMM MET PROC CAR
[2]   Utilizing a disease management approach to improve ESRD patient outcomes [J].
Anand, S ;
Nissenson, AR .
SEMINARS IN DIALYSIS, 2002, 15 (01) :38-40
[3]   Adynamic bone and chronic renal failure:: An overview [J].
Andía, JBC .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2000, 320 (02) :81-84
[4]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[5]   Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661
[6]   Prediction of early death in end-stage renal disease patients starting dialysis [J].
Barrett, BJ ;
Parfrey, PS ;
Morgan, J ;
Barre, P ;
Fine, A ;
Goldstein, MB ;
Handa, SP ;
Jindal, KK ;
Kjellstrand, CM ;
Levin, A ;
Mandin, H ;
Muirhead, N ;
Richardson, RMA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (02) :214-222
[7]   The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].
Besarab, A ;
Bolton, WK ;
Browne, JK ;
Egrie, JC ;
Nissenson, AR ;
Okamoto, DM ;
Schwab, SJ ;
Goodkin, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590
[8]  
Bhagat K., 1999, Central African Journal of Medicine, V45, P187
[9]   SIMILAR RATE OF PROGRESSION IN THE PREDIALYSIS PHASE IN TYPE-I AND TYPE-II DIABETES-MELLITUS [J].
BIESENBACH, G ;
JANKO, O ;
ZAZGORNIK, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) :1097-1102
[10]   Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
London, GM .
HYPERTENSION, 2001, 38 (04) :938-942